Non-profit Enroll America, the nation’s largest health care enrollment coalition, is working with the Ad Council to encourage women to sign up for health insurance under the Affordable Care Act during the next open enrollment period, which runs from November 15, 2014 through February 15, 2015.
To raise awareness, Enroll America is working with the Ad Council to continue its successful “Take Care, People” integrated public service advertising (PSA) campaign encouraging the uninsured, particularly women, to enroll. According to the U.S. Department of Labor, women make 80% of the health care decisions for their families. Women are also 47% more likely than their male counterparts to share information about health care with their friends, family and community. Lack of awareness is a critical issue among women, however, with 79% of those in the Enroll America study saying they do not know enough about the new law.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7368551-enroll-america-ad-council-second-affordable-care-act-open-enrollment-period-begins/
Many women are familiar with the brand name BOTOX® Cosmetic (onabotulinumtoxinA), but a new study from SheSpeaks™, an online community of women, reveals what they really want to know about it.1 To address the most common questions women have – and there are nearly 10 million women who are considering treatment2 – Allergan Inc., maker of BOTOX® Cosmetic, teamed up with SheSpeaks to identify these questions and provide answers.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7334951-allergan-shespeaks-survey-reveals-what-u-s-women-really-want-to-know-about-botox-cosmetic/
1 in 3 women will notice hair thinning in her lifetime, and it can start as early as her 20’s. Today, the hair regrowth category leader, ROGAINE® Brand, announced the official launch to market of Women's ROGAINE® 5% Minoxidil Topical Aerosol, the first and only FDA-approved, once-daily use treatment for Female Pattern Hair Loss containing 5 percent minoxidil in an elegant foam formula. Minoxidil is the only topical ingredient FDA-approved to help regrow hair.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7368851-introducing-women-s-rogaine-5-percent-minoxidil-topical-aerosol-fda-approved/
Dixon Hughes Goodman (DHG), one of the nation’s top 20 public accounting firms, announced today that the firm has admitted 12 professionals into the partnership. The promotions will become effective November 1. The class—which is comprised of professionals from all of DHG’s geographic regions and core service lines—illustrates DHG’s commitment to developing thoughtful leaders that can drive today’s ever-changing business world.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7344651-dhg-ceo-welcomes-new-partners/
An estimated 15 million babies around the world are born premature each year and more than one million of them do not survive their early birth. Although the United States has seen sustained improvement in its preterm birth rate, it has one of the highest rates of preterm birth of any industrialized country.
Next month, organizations and individuals around the globe will observe Prematurity Awareness Month and World Prematurity Day. World-famous photographer Anne Geddes, and international superstars Thalia and Hilary Duff, will join other celebrity parents to spread the word that premature birth is a very serious health problem for babies worldwide.
To view the Multimedia News Release, go http://www.multivu.com/players/English/65164-march-of-dimes-march-for-babies-2014/
In its 25th year, Toyota’s annual Opportunity Exchange (OE) has resulted in more than $250 million in contracts for M/WBEs.
The two-day event – which included best-practice seminars, panel discussions and a trade show – concluded Tuesday, Oct. 28, at the Duke Energy Convention Center in downtown Cincinnati. Toyota Motor Engineering & Manufacturing North America (TEMA) started OE with about 100 attendees, and it has grown to become one of the largest minority business events in the country – attracting nearly 2,000 people who attend the event free of charge.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7353151-toyota-opportunity-exchange-minority-woman-owned-business-enterprises/
In anticipation of the 2014 holiday season, POND’S®, the classic beauty brand trusted by generations of loyal followers, is teaming up with the Rockettes, the legendary precision dance company, to encourage women to kick off an effective, Rockettes-approved skincare routine and enter for a chance to go behind the curtain at Radio City Music Hall this December.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7335551-pond-s-skincare-makeup-removers-rockettes-tested-approved/
Understanding the burden of metastatic breast cancer (MBC), and the toll it takes on patients and their loved ones, Eisai Inc. announced today the launch of mbcInfoCenter.com, a new online portal designed to provide important resources that may help women with MBC manage their disease and focus on their health and wellness.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7342251-eisai-launches-mbc-infocenter-for-women-with-metastatic-breast-cancer/
Third Box, a new resource for the unsure women in an unintended pregnancy, today announced results of a recent survey demonstrating that despite the current polarizing two-box political approaches, one in four women in unintended pregnancies are unsure of what to do. This data corresponds with the organization’s expansion of its reach to women in California regions, and its footprint across the country providing free medical and emotional care, in a space apart from ideology or politics, with no bias toward outcome.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7339251-third-box-sponsored-study-women-in-unintended-pregnancies-uncertain-national-expansion-campaign/
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
Hologic, Inc. (NASDAQ: HOLX) is kicking off Breast Cancer Awareness Month with the announcement that the Company's groundbreaking 3D mammography exam, available on the Selenia Dimensions platform, will be introduced to consumers today as Genius 3D Mammography. Hologic’s Genius 3D Mammography is the only 3D exam approved by the FDA as clinically superior to traditional mammography.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7254155-hologic-new-consumer-awareness-campaign-mammography-technology/
More than 173,000 women in the United States are living with metastatic breast cancer and each has a story to tell. AstraZeneca is launching a nationwide photo-sharing campaign to provide them another way to share their inspiration, experiences and strengths with others.
To show their support, women living with metastatic breast cancer can upload photos of themselves on social media using the campaign hashtag #MBCStrength. Photos posted on Twitter by October 1, 2014 and tagged with #MBCStrength will be considered for a Times Square display in New York City on the fifth anniversary of Metastatic Breast Cancer Awareness Day on October 13, 2014.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7305551-mymbcstory-astrazeneca-encourages-women-with-metastatic-breast-cancer-to-share/
